Trastuzumab

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17570 publications

Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study.

Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study.

Journal: European journal of breast health

Published: June 19, 2026

Real-Time Monitoring of Trastuzumab Monoclonal Antibodies Using Electrochemical Aptamer-Based Sensors.

Real-Time Monitoring of Trastuzumab Monoclonal Antibodies Using Electrochemical Aptamer-Based Sensors.

Journal: ACS sensors

Published: June 18, 2026

Evaluation of zongertinib for the treatment of metastatic non-squamous non-small cell lung cancer with HER2 TKD activating mutation.

Evaluation of zongertinib for the treatment of metastatic non-squamous non-small cell lung cancer with HER2 TKD activating mutation.

Journal: Expert opinion on pharmacotherapy

Published: June 18, 2026

A Case Report: A Rare Casr Mutation Associated with HER2-Positive Breast Cancer.

A Case Report: A Rare Casr Mutation Associated with HER2-Positive Breast Cancer.

Journal: Experimental oncology

Published: June 14, 2026

Quantitative live-imaging platform to probe the spatio-temporal internalization and lysosomal degradation of therapeutic antibodies and ADCs in cells.

Quantitative live-imaging platform to probe the spatio-temporal internalization and lysosomal degradation of therapeutic antibodies and ADCs in cells.

Journal: Journal of immunoassay & immunochemistry

Published: June 13, 2026

Assessment of Out-of-Pocket Expenditure of HER2-Positive Breast Cancer Patients in a Tertiary Cancer Center and Private Clinics in the Philippines.

Assessment of Out-of-Pocket Expenditure of HER2-Positive Breast Cancer Patients in a Tertiary Cancer Center and Private Clinics in the Philippines.

Journal: Acta medica Philippina

Published: June 08, 2026

"Outstanding" ADC Candidates Emerge for SCLC, Other Cancers.

"Outstanding" ADC Candidates Emerge for SCLC, Other Cancers.

Journal: Cancer discovery

Published: June 05, 2026

Safety of concurrent T-DM1 and radiation therapy in HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy.

Safety of concurrent T-DM1 and radiation therapy in HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy.

Journal: International journal of radiation biology

Published: June 04, 2026

Loss of Flotillin-2 enhances trastuzumab emtansine internalization and cytotoxicity by relieving negative regulation of HER2 internalization in HER2-amplified cancers.

Loss of Flotillin-2 enhances trastuzumab emtansine internalization and cytotoxicity by relieving negative regulation of HER2 internalization in HER2-amplified cancers.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2026

A Novel Patient-Derived Xenograft Model of Inflammatory Breast Cancer.

A Novel Patient-Derived Xenograft Model of Inflammatory Breast Cancer.

Journal: Research square

Published: June 04, 2026

Recent Advances in the Treatment of HER2-Altered Solid Tumors

Recent Advances in the Treatment of HER2-Altered Solid Tumors

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: June 04, 2026

Development of Novel Lysosome-Targeting Chimera by Non-covalent-Type Fc-IGF2 Complex (Fc-LYTAC) for Target Membrane Protein Degradation.

Development of Novel Lysosome-Targeting Chimera by Non-covalent-Type Fc-IGF2 Complex (Fc-LYTAC) for Target Membrane Protein Degradation.

Journal: Chemical & pharmaceutical bulletin

Published: June 03, 2026

Showing 1-12 of 17,570

Last Updated: 06/30/2026